This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Milford, MA-based, Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company’s products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. Waters Division (88.8% of total revenues in 2019) - High Performance and Ultra Performance Liquid Chromatography (HPLC and UPLC). TA Division (11.2% of total revenues in 2019)- Thermal Analysis, Rheometry and Calorimetry.
Alphabet (GOOGL) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Alphabet (GOOGL) reports weak fourth-quarter revenues owing to declining search advertising growth and lower-than-expected YouTube sales.
The Zacks Analyst Blog Highlights: Waters, Neurocrine Biosciences, Spirit Airlines, NuStar Energy and The RMR Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Waters, Neurocrine Biosciences, Spirit Airlines, NuStar Energy and The RMR Group
Cypress (CY) Q4 Earnings In Line With Estimates, Sales Lag
by Zacks Equity Research
Cypress' (CY) fourth-quarter earnings are in line with the Zacks Consensus Estimate.
Maxim (MXIM) Surpasses Earnings & Revenue Estimates in Q2
by Zacks Equity Research
Maxim Integrated Products (MXIM) reports strong fiscal second-quarter results driven by strength in end-market demand. However, the consumer end-market demand remains soft in the quarter.
5 Top Stocks Set to Beat Earnings Estimates Next Week
by Nalak Das
Although, expectations for fourth-quarter 2019 earnings are negative at present, results so far are far better than initially anticipated.
Waters (WAT) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Waters' (WAT) fourth-quarter 2019 results are likely to have benefited from new product introductions. However, uncertainties in China and Europe remained concerns.
Lam Research (LRCX) Q2 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Lam Research (LRCX) reports strong fiscal second-quarter results on the back of solid execution, and strength in foundry and logic.
Apple's (AAPL) Q1 Earnings Beat, iPhone Sales Increase Y/Y
by Zacks Equity Research
Apple's (AAPL) first-quarter fiscal 2020 results reflect robust performance of iPhone, Services and Wearables despite lower iPad and Mac sales.
Waters (WAT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teradyne (TER) Surpasses Q4 Earnings & Revenue Estimates
by Zacks Equity Research
Teradyne (TER) reports impressive fourth-quarter results driven by strength in semiconductor test and LitePoint wireless shipments.
Amphenol (APH) Q4 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Amphenol's (APH) fourth-quarter 2019 results reflect a lackluster performance in communications end markets.
4 S&P 500 Tech Stocks to Buy This Earnings Season
by Aniruddha Ganguly
Here we pick four S&P 500 technology stocks that are well poised to provide solid returns in 2020.
Intel (INTC) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Benefits of robust adoption of Xeon processors are likely to get reflected in Intel's (INTC) Q4 results. However, sluggishness in the PC business is expected to have affected performance.
Waters to Buy Andrew Alliance, Expand Technology Portfolio (Revised)
by Zacks Equity Research
Waters (WAT) agrees to acquire Andrew Alliance in a bid to expand technology portfolio.
What's in Store for Taiwan Semiconductor (TSM) Q4 Earnings?
by Zacks Equity Research
Taiwan Semiconductor's (TSM) fourth-quarter results are likely to have benefited from robust technology portfolio and new product introductions.
Waters to Buy Andrew Alliance, Expand Technology Portfolio
by Zacks Equity Research
Waters (WAT) agrees to acquire Andrew Alliance in a bid to expand the technology portfolio.
6 Technology Stocks Set to Beat Estimates This Earnings Season
by Aniruddha Ganguly
Here we pick six technology stocks that are likely to post positive earnings surprises this season.
Scientific Instruments Industry Outlook: Prospects Look Good
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry is benefiting from solid prospects in emerging markets, robust end-market demand and increasing spending on health care.
Waters (WAT) Up 4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Q3 Earnings In Line, Revenues Miss Estimates
by Zacks Equity Research
Waters' (WAT) third-quarter results hurt by softness in U.S. and Governmental & Academic market.
Waters (WAT) Meets Q3 Earnings Estimates
by Zacks Equity Research
Waters (WAT) delivered earnings and revenue surprises of 0.00% and -2.04%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Waters (WAT) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Waters' (WAT) third-quarter 2019 results are likely to have benefited from solid momentum across pharma market, U.S. and China.
Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for DEF
Waters (WAT) Down 2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Scientific Instruments Industry Outlook: Prospects Look Good
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry is benefiting from solid prospects in emerging markets, robust end-market demand and increasing spending on health care.